GTBP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
GT Biopharma Inc (GTBP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or trends to support an immediate investment decision.
The MACD histogram is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 46.285, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (0.491), with resistance at 0.556 and support at 0.426. Overall, the technical indicators do not suggest a strong buy signal.
The stock showed a 6.72% pre-market gain and a 4.06% regular market gain, indicating short-term positive price movement. MACD is also expanding positively.
declining significantly YoY. No recent congress trading data or valuation data available.
In Q3 2025, revenue remained at 0 with no growth YoY. Net income dropped by -4.49% YoY to -$3.26M, and EPS declined by -45.75% YoY to -0.83. Gross margin remained at 0, showing no improvement.
No data available for trend analysis or analyst ratings.
